Dr. Ryan Alexander McMillan, MD

Dr. McMillan practices at United Hospital in Saint Paul, Minnesota, part of Sutter Health.

Dr. McMillan's NPI, 1194220194, was assigned on March 29, 2018. Dr. McMillan graduated from Loyola University of Chicago, Stritch School of Medicine in 2018. Dr. McMillan holds Minnesota license 66186.

Dr. McMillan's primary practice is United Hospital, at 333 North Smith Avenue, Saint Paul, MN 55102 in Ramsey County. The practice phone is (763) 236-8205.

Dr. McMillan's primary practice is United Hospital in Saint Paul, Minnesota, part of Sutter Health. Dr. McMillan is also affiliated with Abbott Northwestern Hospital. The medical group on file is Buffalo Hospital. Dmand AI also links Dr. McMillan to 1 more hospital, 1 group practice or clinic, 1 urgent care center and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. McMillan practices, 5 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. McMillan's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. McMillan is licensed in Minnesota.

CMS data shows 453 Medicare services from Dr. McMillan across 8 procedure codes in 2024, for 225 Medicare patients. Medicare paid $37,938 for them. Every service was in an office.

CMS counts 225 Medicare patients who saw Dr. McMillan in 2024. The largest group is 65 to 74, with 112 patients. 67% of them have high cholesterol, and 59% have high blood pressure. 12% are also on Medicaid. Their average risk score is 1.11, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. McMillan's median patient age at 48, with 49% women.

In 2024, Dr. McMillan wrote 781 Medicare Part D claims for 306 patients. 98% of them were for generic drugs. CMS names the drug for 686 of them, across 17 drugs with 11 or more claims each, at $12,553 in total drug cost. In 2023, CMS named 59 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. McMillan for performance year 2024, reported as part of a group. Dr. McMillan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. McMillan as offering telehealth.

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 12 papers to Dr. McMillan, published from 2021 to 2024. 2021 was the busiest year, with 5. The most frequent topics are Esthesioneuroblastoma, Olfactory, Nasal Cavity and Nose Neoplasms. Dr. McMillan has published most often in Int Forum Allergy Rhinol. Dr. McMillan's most frequent co-authors are Garret Wayne Choby, MD, Dale Ekbom, MD and Semirra Lynn Bayan, MD.

CMS Open Payments shows 19 general payments to Dr. McMillan from 6 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 73% of the total. Acclarent, Inc paid the most, $657.

Dr. McMillan graduated from Loyola University of Chicago, Stritch School of Medicine in 2018.